Xue Min Zuo
Vorstandsvorsitzender bei Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd.
Profil
Xue Min Zuo is currently the Chairman-Supervisory Board at Shanxi C&Y Pharmaceutical Group Co., Ltd.
since 2020.
Additionally, Mr. Zuo holds the position of General Manager at Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd., Zhejiang Hailisheng Pharmaceutical Co., Ltd., and Hangzhou Enshi Gene Technology Co., Ltd.
since 2013, 2014, and 2014 respectively.
Mr. Zuo previously served as the Deputy General Manager at Shanxi C&Y Pharmaceutical Group Co., Ltd.
from 2007 to 2013.
Aktive Positionen von Xue Min Zuo
| Unternehmen | Position | Beginn |
|---|---|---|
Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd.
 Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Hangzhou, China. Hangzhou Aoyi Pollen Pharmaceutical Co. was acquired by Hangzhou Baoling Group Co. Ltd. on February 27, 2015 for $15.26 million. Xue Min Zuo has been the CEO of the Chinese company since 2013. | Vorstandsvorsitzender | 01.09.2013 |
Zhejiang Hailisheng Pharmaceutical Co., Ltd.
 Zhejiang Hailisheng Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Zhejiang Hailisheng Pharmaceutical Co., Ltd. is a pharmaceutical company based in Zhoushan, CN. Zhejiang Hailisheng Pharmaceutical Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. from Zhoushan Yuantai Foodstuff Co., Ltd. on March 27, 2012 for $23.83 million. Zhejiang Hailisheng Pharmaceutical Co. manufactures and distributes pharmaceutical products. Xue Min Zuo has been the CEO of the Chinese company since 2014. | Vorstandsvorsitzender | 01.12.2014 |
Hangzhou Enshi Gene Technology Co., Ltd.
 Hangzhou Enshi Gene Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Shanxi C & Y Pharmaceutical Group Co., Ltd., Hangzhou Enshi Gene Technology Co., Ltd. is a company that engages in the research and development of human gene purification & preservation technology. Hangzhou Enshi Gene Technology Co., Ltd. is based in Hangzhou, China. Hangzhou Enshi Gene Technology Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. on December 26, 2014 for $16.29 million. The Chinese company was founded in 2008. Xue Min Zuo has been the CEO of the company since 2014. | Vorstandsvorsitzender | 01.12.2014 |
Ehemalige bekannte Positionen von Xue Min Zuo
| Unternehmen | Position | Ende |
|---|---|---|
| SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD. | Vorsitzender | 01.02.2023 |
| SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD. | Vorstandsvorsitzender | 31.05.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SHANXI C&Y PHARMACEUTICAL GROUP CO.,LTD. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd.
Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Hangzhou Aoyi Pollen Pharmaceutical Co. Ltd. is a pharmaceutical company that manufactures and distributes pharmaceutical products. The company is based in Hangzhou, China. Hangzhou Aoyi Pollen Pharmaceutical Co. was acquired by Hangzhou Baoling Group Co. Ltd. on February 27, 2015 for $15.26 million. Xue Min Zuo has been the CEO of the Chinese company since 2013. | Health Technology |
Zhejiang Hailisheng Pharmaceutical Co., Ltd.
Zhejiang Hailisheng Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Shanxi C&Y Pharmaceutical Group Co., Ltd., Zhejiang Hailisheng Pharmaceutical Co., Ltd. is a pharmaceutical company based in Zhoushan, CN. Zhejiang Hailisheng Pharmaceutical Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. from Zhoushan Yuantai Foodstuff Co., Ltd. on March 27, 2012 for $23.83 million. Zhejiang Hailisheng Pharmaceutical Co. manufactures and distributes pharmaceutical products. Xue Min Zuo has been the CEO of the Chinese company since 2014. | Health Technology |
Hangzhou Enshi Gene Technology Co., Ltd.
Hangzhou Enshi Gene Technology Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Shanxi C & Y Pharmaceutical Group Co., Ltd., Hangzhou Enshi Gene Technology Co., Ltd. is a company that engages in the research and development of human gene purification & preservation technology. Hangzhou Enshi Gene Technology Co., Ltd. is based in Hangzhou, China. Hangzhou Enshi Gene Technology Co. was acquired by Shanxi C&Y Pharmaceutical Group Co., Ltd. on December 26, 2014 for $16.29 million. The Chinese company was founded in 2008. Xue Min Zuo has been the CEO of the company since 2014. | Commercial Services |
